136942
Last Update Posted: 2021-02-18
Recruiting has ended
All Genders accepted | 18 Years-80 Years |
370 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol
The proportion of patients achieving LDL-C target as defined by Swiss cholesterol recommendations (AGLA-recommendations) across starting doses of 10 mg, 20 mg, 40 mg, and 80 mg of atorvastatin.
Eligibility
Relevant conditions:
Hyperlipidemia
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov